Literature DB >> 31469012

Increase and diversity of carbapenemase-producing Escherichia coli isolates, Italy.

Serena Simoni1, Sara Caucci1, Andrea Brenciani1, Gianluca Morroni1, Eleonora Giovanetti2, Stefano Menzo1, Bruna Facinelli1, Marina Mingoia1.   

Abstract

Aim: This study reports on a surveillance in an Italian hospital focused on carbapenemase-producing Escherichia coli (CP-Ec). Materials & methods: Eighteen isolates (nine from clinical specimens and nine from rectal swab) were characterized for antibiotic susceptibilities, typing features, main carbapenemase, extended-spectrum ß-lactamases (ESBLs) and other bla genes, and their transferability by conjugation and transformation.
Results: An increase in CP-Ec isolates was observed during 3-year surveillance period. Compared with the clinical isolates, all belonging to one sequence type (ST), ST131, those from rectal swab were very heterogeneous and belonged to eight STs. Transfer data confirmed the role of conjugative plasmids in the spreading of carbapenemase genes.
Conclusion: The prevalence of CP-Ec in Italy has risen, with a substantial increase over the last year.

Entities:  

Keywords:  VIM, KPC and OXA-48 types; carbapenemases; coproduction of VIM-1 and KPC-2; β-lactamases

Mesh:

Substances:

Year:  2019        PMID: 31469012     DOI: 10.2217/fmb-2019-0069

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  5 in total

1.  fosM, a New Family of Fosfomycin Resistance Genes Identified in Bacterial Species Isolated from Human Microbiota.

Authors:  Sami Khabthani; Mouna Hamel; Sophie Alexandra Baron; Seydina M Diene; Jean-Marc Rolain; Vicky Merhej
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

2.  Genomic characterization of an emerging blaKPC-2 carrying Enterobacteriaceae clinical isolates in Thailand.

Authors:  Anusak Kerdsin; Saowarat Deekae; Sunee Chayangsu; Rujirat Hatrongjit; Peechanika Chopjitt; Dan Takeuchi; Yukihiro Akeda; Kazunori Tomono; Shigeyuki Hamada
Journal:  Sci Rep       Date:  2019-12-06       Impact factor: 4.379

3.  Genomic Characterization of VIM and MCR Co-Producers: The First Two Clinical Cases, in Italy.

Authors:  Vittoria Mattioni Marchetti; Ibrahim Bitar; Mario Sarti; Elena Fogato; Erika Scaltriti; Chiara Bracchi; Jaroslav Hrabak; Stefano Pongolini; Roberta Migliavacca
Journal:  Diagnostics (Basel)       Date:  2021-01-06

4.  Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections.

Authors:  Gianluca Morroni; Raffaela Bressan; Simona Fioriti; Gloria D'Achille; Marina Mingoia; Oscar Cirioni; Stefano Di Bella; Aurora Piazza; Francesco Comandatore; Carola Mauri; Roberta Migliavacca; Francesco Luzzaro; Luigi Principe; Cristina Lagatolla
Journal:  Antibiotics (Basel)       Date:  2021-11-03

5.  First IncHI2 Plasmid Carrying mcr-9.1, blaVIM-1, and Double Copies of blaKPC-3 in a Multidrug-Resistant Escherichia coli Human Isolate.

Authors:  Serena Simoni; Marina Mingoia; Andrea Brenciani; Maria Carelli; Maria M Lleò; Giovanni Malerba; Carla Vignaroli
Journal:  mSphere       Date:  2021-05-28       Impact factor: 4.389

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.